The carcinoid syndrome.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D008303:Malignant Carcinoid Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D015282:Octreotide; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D013004:Somatostatin; D015282:Octreotide